最新资讯
α 受体阻滞剂的家族史册
1. Ahlquist R P. A study of the adrenotropic receptors[J]. American Journal of Physiology-Legacy Content, 1948, 153(3): 586-600.
2. Wenger N K, Greenbaum L M. From adrenoceptor mechanisms to clinical therapeutics: Raymond Ahlquist, PhD, 1914–1983[J]. Journal of the American College of Cardiology, 1984, 3(2 Part 1): 419-421.
3. Moran N C, Perkins M E. Adrenergic blockade of the mammalian heart by a dichloro analogue of isoproterenol[J]. Journal of pharmacology and experimental therapeutics, 1958, 124(3): 223-237.
4. Beilin L J, Juel-Jensen B E. Alpha and beta adrenergic blockade in hypertension[J]. The Lancet, 1972, 299(7758): 979-982.
5. Starke K, Montel H, Gayk W, et al. Comparison of the effects of clonidine on pre-and postsynaptic adrenoceptors in the rabbit pulmonary artery[J]. Naunyn-Schmiedeberg's archives of pharmacology, 1974, 285(2): 133-150.
6. Dubocovich M L, Langer S Z. Negative feedback regulation of noradrenaline release by nerve stimulation in the perfused cat's spleen: differences in potency of phenoxybenzamine in blocking the pre‐and post‐synaptic adrenergic receptors[J]. The Journal of physiology, 1974, 237(3): 505-519.
7. Caine M, Pfau A, Perlberg S. The use of alpha adrenergic blockers in benign prostatic obstruction. Br J Urol. 1976; 48:255–263.
8. Cambridge D, Davey M J, Massingham R. Prazosin, a selective antagonist of post-synaptic alpha-adrenoceptors [proceedings][J]. British journal of pharmacology, 1977, 59(3): 514P.
9. Morrow A L, Creese I. Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H] WB4104 and [3H] prazosin binding[J]. Molecular Pharmacology, 1986, 29(4): 321-330.
10. Titmarsh S, Monk J P. Terazosin[J]. Drugs, 1987, 33(5): 461-477.
11. Langer S Z. History and nomenclature of α1-adrenoceptors[J]. European urology, 1999, 36(Suppl. 1): 2-6.
12. Fulton B, Wagstaff A J, Sorkin E M. Doxazosin[J]. Drugs, 1995, 49(2): 295-320.
13. Faure C, Pimoule C, Arbilla S, et al. Expression of α1-adrenoceptor subtypes in rat tissues: implications for α1-adrenoceptor classification[J]. European Journal of Pharmacology: Molecular Pharmacology, 1994, 268(2): 141-149.
14. Shibata K, Foglar R, Horie K, et al. KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues[J]. Molecular pharmacology, 1995, 48(2): 250-258.
15. Chapple C R, Wyndaele J J, Nordling J, et al. Tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist. A meta-analysis of two randomized, placebo-controlled, multicentre studies in patients with benign prostatic obstruction (symptomatic BPH). European Tamsulosin Study Group[J]. 1996.
16. Tatemichi S, Kobayashi K, Maezawa A, et al. Alpha1-adrenoceptor subtype selectivity and organ specificity of silodosin (KMD-3213)[J]. Yakugaku zasshi: Journal of the Pharmaceutical Society of Japan, 2006, 126: 209-216.
17. 那彦群. 新型高选择性α1A-肾上腺素受体阻滞剂赛洛多辛治疗良性前列腺增生的临床应用[J]. 临床药物治疗杂志, 2015(2):24-28.
18. Gacci M, Ficarra V, Sebastianelli A, et al. Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and meta-analysis. J Sex Med. 2014; 11(6):1554-1566.
19. 国家卫生计生委合理用药专家委员会. 高血压合理用药指南（第2版）.中国医学前沿杂志（电子版）.2017. 9(7):28-126.
20. 周辉良，袁华，唐松喜，等. 单用α1受体阻滞剂与加用M受体阻滞剂治疗BPH/OAB症状的对照研究. 中华泌尿外科杂志. 2012; 33(9):685-8.
21. European Association of Urology Guidelines 2018.
22. 沈子肆，沈周俊. α1受体阻滞剂改善早泄症状的研究. 国际泌尿系统杂志. 2009; 29(1): 65-7.
23. Thakkinstian A, Attia J, Anothaisintawee T, et al. α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome. BJU Int. 2012; 110(7): 1014-22.
24. 那彦群，叶章群，孙颖浩，等. 中国泌尿外科疾病诊断治疗指南（2014版）.人民卫生出版社. 2014.
25. Lepor H, Kazzazi A, Djavan B. α-blockers for benign prostatic hyperplasia: the new era. Curr Opin Urol, 2012, 22(1): 7-15.